All Outputs (4)

Harvesting human prostate tissue material and culturing primary prostate epithelial cells (2016)
Book Chapter
Frame, F. M., Pellacani, D., Collins, A. T., & Maitland, N. J. (2016). Harvesting human prostate tissue material and culturing primary prostate epithelial cells. In I. J. McEwan (Ed.), The nuclear receptor superfamily: methods and protocols (181-201). New York, NY: Humana Press. https://doi.org/10.1007/978-1-4939-3724-0_12

In order to fully explore the biology of a complex solid tumor such as prostate cancer, it is desirable to work with patient tissue. Only by working with cells from a tissue can we take into account patient variability and tumor heterogeneity. Cell l... Read More about Harvesting human prostate tissue material and culturing primary prostate epithelial cells.

Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium (2016)
Journal Article
Archer, L. K., Frame, F. M., & Maitland, N. J. (2017). Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium. Journal of Steroid Biochemistry and Molecular Biology, 166, 68-83. https://doi.org/10.1016/j.jsbmb.2016.05.006

Prostate cancer is the most common cancer of men in the UK and accounts for a quarter of all new cases. Although treatment of localised cancer can be successful, there is no cure for patients presenting with invasive prostate cancer and there are les... Read More about Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium.

An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells (2016)
Journal Article
Peitzsch, C., Cojoc, M., Hein, L., Kurth, I., Mäbert, K., Trautmann, F., …Dubrovska, A. (2016). An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells. Cancer Research, 76(9), 2637-2651. https://doi.org/10.1158/0008-5472.can-15-2116

Radiotherapy is a mainstay of curative prostate cancer treatment, but risks of recurrence after treatment remain significant in locally advanced disease. Given that tumor relapse can be attributed to a population of cancer stem cells (CSC) that survi... Read More about An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells.

Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future (2016)
Journal Article
Hirst, A. M., Frame, F. M., Arya, M., Maitland, N. J., & O’Connell, D. (2016). Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future. Tumor Biology, 37(6), 7021-7031. https://doi.org/10.1007/s13277-016-4911-7

The field of plasma medicine has seen substantial advances over the last decade, with applications developed for bacterial sterilisation, wound healing and cancer treatment. Low temperature plasmas (LTPs) are particularly suited for medical purposes... Read More about Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future.